Motif Bio #MTFB Amur Minerals #AMC and Alan Green on #SPE #FDBK #STM

Mar 20, 2018, 01:58 PM

On the Vox Markets Podcast Today - 20th March 2018

Graham Lumsden, CEO of Motif Bio #MTFB explains why they are delaying their New Drug Application submission for Iclaprim to the U.S. Food & Drug Administration (FDA).

(Interview starts at 1 minute 16 seconds)

Robin Young, CEO of Amur Minerals #AMC talks about progress at the company, which has the largest undeveloped nickel sulphide project, located immediately adjacent to the three largest nickel consuming nations of China, Korea and Japan.

(Interview starts at 9 minutes 26 seconds)

Alan Green CEO of Brand Communications talks about: Sopheon #SPE Feedback #FDBK & STM Group #STM

(Interview starts at 16 minutes 35 seconds)

The Top 5 Most Followed Companies on Vox Markets in the last 24 hours & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.

(Feature starts at 36 minutes 11 seconds)

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast